Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Equities
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.81 CNY | +0.21% |
|
+1.40% | +6.75% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 14.43x | 2.7x | 0.7x | 0.6x | 4.96x | 7.81x | 4.71% | 3.15B | ||
| 21.22x | 1.87x | 2.4x | 0.94x | 14.24x | 15.74x | -.--% | 18.52B | ||
| 26.37x | 3.21x | 0.46x | 1.38x | 21.37x | 21.85x | -.--% | 8.75B | ||
| 16.09x | 1.68x | 2.5x | 0.71x | 7.36x | 9.25x | 2.11% | 5.75B | ||
| 14.55x | 2.19x | 0.89x | 0.94x | 6.77x | 8.66x | 2.93% | 4.1B | ||
| 17.12x | 7.73x | 2.54x | 1.05x | 7.8x | 10.84x | 3.78% | 3.49B | ||
| 15.18x | 4.53x | 9.1x | 1.28x | 7.82x | 14.49x | 5.87% | 3.42B | ||
| 35.72x | - | 1.14x | - | - | - | - | 2.32B | ||
| 25.91x | 4.93x | 6.71x | 0.81x | 10.11x | 15.72x | 1.55% | 1.9B | ||
| 53.4x | 5.87x | 1.26x | 1.58x | 18.14x | 34.75x | - | 1.19B | ||
| -47.21x | 2.08x | 1.01x | 0.35x | 14.03x | 151.42x | 0.03% | 1.1B | ||
| 13.84x | 0.99x | 0.13x | 0.34x | 3.29x | 6.78x | 3.67% | 1.09B | ||
| 10.43x | 2.48x | 0.51x | 0.93x | 7.14x | 13.1x | 5.99% | 1.08B | ||
| 26.86x | 7.25x | 1.04x | 0.97x | 13.25x | 20.96x | 1.34% | 820M | ||
| 14.06x | 1.81x | 1.31x | - | - | - | 0.39% | 696M | ||
| 8.62x | 1x | 0.29x | 0.27x | 4.15x | 5.12x | 3.19% | 611M | ||
| Average | 16.66x | 3.35x | 2.00x | 0.87x | 10.03x | 24.03x | 2.54% | 3.62B | |
| Weighted average by Cap. | 19.67x | 2.92x | 2.23x | 0.97x | 12.21x | 17.51x | 1.63% |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















